What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Gene
- Genetics
Her primary scientific interests are in Immunology, Atypical hemolytic uremic syndrome, Factor H, Internal medicine and Kidney disease.
Immunology is represented through her Complement system, Hemolytic anemia, Alternative complement pathway, CD46 and Thrombotic thrombocytopenic purpura research.
Her Atypical hemolytic uremic syndrome research is multidisciplinary, relying on both Complement factor I, Treatment options, Disease and Intensive care medicine.
Her Factor H research incorporates themes from Penetrance, Complement factor B, Gene and Gene mutation.
Marina Noris interconnects Gastroenterology and Endocrinology in the investigation of issues within Internal medicine.
Her Kidney disease course of study focuses on Kidney and Blood vessel, Renal function and Pathophysiology.
Her most cited work include:
- Atypical Hemolytic–Uremic Syndrome (932 citations)
- Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype (611 citations)
- Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome (550 citations)
What are the main themes of her work throughout her whole career to date?
Marina Noris mainly investigates Immunology, Internal medicine, Atypical hemolytic uremic syndrome, Complement system and Endocrinology.
Her study looks at the intersection of Immunology and topics like Transplantation with Immune tolerance.
Marina Noris regularly ties together related areas like Gastroenterology in her Internal medicine studies.
Her Atypical hemolytic uremic syndrome research incorporates elements of Mutation, Eculizumab and CD46.
Her research investigates the link between Complement system and topics such as Glomerulopathy that cross with problems in Disease.
The concepts of her Hemolytic anemia study are interwoven with issues in Platelet and Pathogenesis.
She most often published in these fields:
- Immunology (52.34%)
- Internal medicine (30.47%)
- Atypical hemolytic uremic syndrome (21.09%)
What were the highlights of her more recent work (between 2013-2020)?
- Immunology (52.34%)
- Atypical hemolytic uremic syndrome (21.09%)
- Complement system (19.92%)
In recent papers she was focusing on the following fields of study:
Marina Noris mostly deals with Immunology, Atypical hemolytic uremic syndrome, Complement system, Alternative complement pathway and Internal medicine.
Her Immunology study combines topics in areas such as Glomerulopathy and Cell biology.
Her Atypical hemolytic uremic syndrome research includes elements of Mutation, Factor H, Thrombotic microangiopathy and Eculizumab.
The Complement system study combines topics in areas such as Membranoproliferative glomerulonephritis, Endothelium, Pathogenesis and Von Willebrand factor.
Marina Noris has included themes like Autoantibody, Complement factor B, Kidney and CD46 in her Alternative complement pathway study.
The various areas that Marina Noris examines in her Internal medicine study include Gastroenterology and Endocrinology.
Between 2013 and 2020, her most popular works were:
- Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference (254 citations)
- Dynamics of complement activation in aHUS and how to monitor eculizumab therapy (195 citations)
- Atypical aHUS: State of the art. (154 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Genetics
Complement system, Immunology, Atypical hemolytic uremic syndrome, Alternative complement pathway and Glomerulopathy are her primary areas of study.
Her Complement system research focuses on Membranoproliferative glomerulonephritis and how it connects with Factor H, Hematology, Endothelium and Complement membrane attack complex.
Her Immunology research is multidisciplinary, incorporating perspectives in Acute kidney injury and Cell biology.
Her biological study spans a wide range of topics, including Lupus nephritis, Internal medicine and Pediatrics.
Her study looks at the relationship between Internal medicine and topics such as Eculizumab, which overlap with Thrombotic microangiopathy.
Her studies deal with areas such as Haemolytic-uraemic syndrome, Kidney and CD46 as well as Alternative complement pathway.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
